Clinical Trials in Austin

Showing 9821-9840 of 15,205 trials

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876

This study was designed to conduct a comparative trial to further evaluate the safety, immunogenicity and antibody persistence of two doses of Novartis MenACWY conjugate vaccine, given 2 months apart, versus one dose of Novartis MenACWY conjugate vaccine in children 2 through 10 years of age.

Meningococcal DiseaseInfections, Meningococcal

GlaxoSmithKline715 participantsStarted Oct 2012

Birmingham, Alabama, United States • Sacramento, California, United States • Lake Mary, Florida, United States +16 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

NCT01885208

This trial is conducted in Europe and North and South America. The aim of the trial is to investigate the efficacy and safety of semaglutide once-weekly versus exenatide ER (extended release) 2.0 mg once-weekly as add-on to 1-2 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S813 participantsStarted Dec 2013

Anniston, Alabama, United States • Birmingham, Alabama, United States • Pell City, Alabama, United States +143 more locations

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Find Trials by Condition in Austin

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

Indomethacin PK and PD Therapy in Pregnancy

Assessing Superion Clinical Endpoints vs. Decompression

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age